These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2186170)

  • 1. A rapid microassay for hemolytic antibody--its application to immunotoxicological study.
    Yoshida T; Shimamura T; Shigeta S
    J Toxicol Sci; 1990 Feb; 15(1):29-37. PubMed ID: 2186170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(6):611-20. PubMed ID: 4596308
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of 5-fluorouracil on direct and developed spleen hemolysin plaque-forming cells of mice.
    Griswold DE; Uyeki EM
    Arch Ital Patol Clin Tumori; 1969; 12(1):109-14. PubMed ID: 4918910
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody plaque reduction in vitro and in vivo: a rapid assay for immunosuppressive agents.
    Gavin J; Waterbury W; Freidman H
    Transplant Proc; 1969 Mar; 1(1):413-5. PubMed ID: 4944252
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid determination of in vivo and in vitro antibody responses by suspension hemolytic assay.
    Han SB; Oh GT; Yun YP; Min BK; Hyun BH; Kim HM
    J Pharmacol Toxicol Methods; 1996 Sep; 36(1):33-40. PubMed ID: 8872917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of antibody-synthesis with immunosuppressive drugs in parabionts.
    Baenkler HW; Scheiffarth F
    J Med; 1971; 2(3):143-8. PubMed ID: 4944003
    [No Abstract]   [Full Text] [Related]  

  • 7. Integration of the human lymphocyte into immunotoxicological investigations.
    Wood SC; Karras JG; Holsapple MP
    Fundam Appl Toxicol; 1992 Apr; 18(3):450-9. PubMed ID: 1597269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased cellular antibody synthesis caused by immunosuppressive agents].
    Scheiffarth F; Baenkler HW; Flierl W
    Allerg Immunol (Leipz); 1971; 17(2):132-6. PubMed ID: 4261238
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(5):499-505. PubMed ID: 4404912
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression by bisdioxopiperazines: effects on antibody-forming cells and serum titers.
    Tucker DF; Finch MD
    J Natl Cancer Inst; 1972 May; 48(5):1347-54. PubMed ID: 4555496
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased antibody formation in mice exposed to lead.
    Koller LD; Kovacic S
    Nature; 1974 Jul; 250(462):148-50. PubMed ID: 4602028
    [No Abstract]   [Full Text] [Related]  

  • 14. Nucleases in immunity. II. Ineffectiveness of exogenous RNase on the antibody plaque response of immunized mice.
    Chakrabarty AK; Friedman H
    Clin Exp Immunol; 1970 Apr; 6(4):619-25. PubMed ID: 4920600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial endotoxins as immunosuppressive agents.
    Finger H; Fresenius H; Angerer M
    Experientia; 1971 Apr; 27(4):456-8. PubMed ID: 4931871
    [No Abstract]   [Full Text] [Related]  

  • 16. An in vitro analysis of the immune capabilities of mice treated with immunosuppressive drugs.
    Lefkovits H; Reber K; Lefkovits I
    Int Arch Allergy Appl Immunol; 1974; 46(5):689-94. PubMed ID: 4601879
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT).
    Kapp JA; Pierce CW; De la Croix F; Benacerraf B
    J Immunol; 1976 Feb; 116(2):305-9. PubMed ID: 55436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive activity of the pyrrolizidine alkaloid metabolite dehydroheliotridine.
    Percy JJ; Pierce AE
    Immunology; 1971 Aug; 21(2):273-80. PubMed ID: 4937052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunodepressant action of cytosine arabinoside].
    Babichev VA; Uteshev BS; Kudriashov VM; Berezina TA
    Farmakol Toksikol; 1973; 26(4):473-6. PubMed ID: 4597420
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective suppression of humoral and cellular immunity with cytosine arabinoside.
    Griswold DE; Heppner GH; Calabresi P
    Cancer Res; 1972 Feb; 32(2):298-301. PubMed ID: 4550745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.